• Mon news: Novartis wagers billions of dollars on PTC Huntington’s drug. Sanofi China investment deal. FDA rejects Applied filing. Milk-based therapies. BMS challenges 340B. See more on our front page

Esperion

Quote






I guess your advice back when the stock was in the $60 -$77 range was spot on!! And when it continued to drop you talked high flying biotechnology and get into ESPR Pronto. So explain the stocks decline from $77.00 to $ 3.54??? What happened? Explain the poor sales results!, the massive layoffs !! Really serious about long hanging fruit?? Being a thief isn't a noble career choice. You sound like one of the dirt bags in Ann Arbor who continue to squeeze every dime out of the investors. This company isn't worth crap. $3.54 is an embarrassment. BA is the most failed drug launch in 10 years.
 






























Esperion is reported to have negative earnings report coming out 2/22. It's not getting any better. The skeleton crew of reps have failed again and management will try hard to spin something positive out of it as they historically have done in last two years. No amount of word smithing and talk of momentum, upticks, runways, low hanging fruit might be thrown around again to no avail but it won't be enough . The hearse has been reserved for 2/22 in Ann Arbor and the plot has been picked out for BA. RIP uptickers and Scientific Hires and Lipid Experts.
 












Congratulations on a job done. Stock price from $75 to $3.5. Sale force a skeleton crew, sales dismal, no strategy to grow , replaced Kos people with Sanofi people, severance was a joke. This is what happens when you treat people like crap during the interview process bad karma. Rest In Peace . The demise of this company can squarely be placed on the arrogance of management not knowing the cholesterol market place and surrounding themselves with their unqualified buddies to launch a drug.
 






























The stock performance over the past several weeks has been commendable. So many high flying biotechs have been slaughtered but ESPR has held its own. The floor is in for this stock, and it’s going to be a great year with outcomes that will shock the uninformed. Once this market turns look for a huge jump in share price.
 






Don't hold your breath Mr. Ann Arbor. High flying biotech! Just do some more bong hits and realize what an idiot you've become. This stock has been slaughtered for the last two years. The Outcomes won't change a thing. How much longer will Esperion steal money from investors.
 






anonymous said:
The stock performance over the past several weeks has been commendable. So many high flying biotechs have been slaughtered but ESPR has held its own. The floor is in for this stock, and it’s going to be a great year with outcomes that will shock the uninformed. Once this market turns look for a huge jump in share price.
Click to expand...


Sounds like the Esperion Great reset, Pivot, Circle back strategy is being implemented.

Watch out !

Lol...
 






Well the fact is the stock is up about 30% from just a month ago, and that’s a pretty darn good return. The future is brighter as we look out, and the perseverance and resilience of the team is outstanding. It takes time to carve out our niche but their is positive buzz. Those who are outside looking in are expressing their jealousy on this forum, sorry sucka.
 






Very funny Jen Psaki. Are you moonlighting as a spokesperson for Esperion. Explain the cause of the stock free falling from $77.00 to 4.00 and change. Up 30% . Big leap from 3.15 to 4.50. You were a sliver from penny stock range Jen. Just continue to rip investors off with your double talk!
 


















Top Bottom
Back
Quote